Researchers have developed a new, lean mouse with characteristics suggesting that someday, using medication to manipulate a specific protein in humans could emerge as a strategy to treat obesity and disorders associated with excess weight, such as diabetes and metabolic syndrome. To create the hybrid, scientists crossed mice deficient in protein kinase C beta with the C57 black mouse, a common animal used in research for studying diabetes and obesity.